Insilico Medicine’s rentosertib shows potential to slow aging in landmark Phase III trial
Covered by 1 source · 1 article
Rentosertib's success could revolutionize aging treatment, influencing therapies for numerous age-related diseases beyond lung conditions. The post Insilico Medicine’s rentosertib shows potential to slow aging in landmark Phase III trial ap…
Covered by
